{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:24:21Z","timestamp":1790814261986,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"33","license":[{"start":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T00:00:00Z","timestamp":1379894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T00:00:00Z","timestamp":1379894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,8,14]]},"DOI":"10.1038\/onc.2013.375","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T10:14:42Z","timestamp":1379931282000},"page":"4226-4235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Identification of LMX1B as a novel oncogene in human ovarian cancer"],"prefix":"10.1038","volume":"33","author":[{"given":"L","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Vathipadiekal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"Sergent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W B","family":"Growdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Engler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B R","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Birrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Orsulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Mohapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,23]]},"reference":[{"key":"BFonc2013375_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"D Bell","year":"2011","unstructured":"Bell D, Berchuck A, Birrer M, Chien J, Cramer DW, Dao F et al. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609\u2013615.","journal-title":"Nature"},{"key":"BFonc2013375_CR2","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA . Cancer of the ovary. N Engl J Med 2004; 351: 2519\u20132529.","journal-title":"N Engl J Med"},{"key":"BFonc2013375_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1535-6108(04)00002-9","volume":"5","author":"RF Ozols","year":"2004","unstructured":"Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ et al. Focus on epithelial ovarian cancer. Cancer Cell 2004; 5: 19\u201324.","journal-title":"Cancer Cell"},{"issue":"Suppl","key":"BFonc2013375_CR4","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1038\/ng1569","volume":"37","author":"D Pinkel","year":"2005","unstructured":"Pinkel D, Albertson DG . Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005; 37 (Suppl): S11\u2013S17.","journal-title":"Nat Genet"},{"key":"BFonc2013375_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/ijgc-00009577-200503000-00012","volume":"15","author":"A Fishman","year":"2005","unstructured":"Fishman A, Shalom-Paz E, Fejgin M, Gaber E, Altaras M, Amiel A . Comparing the genetic changes detected in the primary and secondary tumor sites of ovarian cancer using comparative genomic hybridization. Int J Gynecol Cancer 2005; 15: 261\u2013266.","journal-title":"Int J Gynecol Cancer"},{"key":"BFonc2013375_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cancergencyto.2004.02.006","volume":"154","author":"O Israeli","year":"2004","unstructured":"Israeli O, Gotlieb WH, Friedman E, Korach J, Friedman E, Goldman B et al. Genomic analyses of primary and metastatic serous epithelial ovarian cancer. Cancer Genet Cytogenet 2004; 154: 16\u201321.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFonc2013375_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1309\/N6X5MB24BP42KP20","volume":"126","author":"D Mayr","year":"2006","unstructured":"Mayr D, Kanitz V, Anderegg B, Luthardt B, Engel J, Lohrs U et al. Analysis of gene amplification and prognostic markers in ovarian cancer using comparative genomic hybridization for microarrays and immunohistochemical analysis for tissue microarrays. Am J Clin Pathol 2006; 126: 101\u2013109.","journal-title":"Am J Clin Pathol"},{"key":"BFonc2013375_CR8","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/nm1125","volume":"10","author":"KW Cheng","year":"2004","unstructured":"Cheng KW, Lahad JP, Kuo WL, Lapuk A, Yamada K, Auersperg N et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med 2004; 10: 1251\u20131256.","journal-title":"Nat Med"},{"key":"BFonc2013375_CR9","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/0008-5472.CAN-06-2366","volume":"67","author":"M Nanjundan","year":"2007","unstructured":"Nanjundan M, Nakayama Y, Cheng KW, Lahad J, Liu J, Lu K et al. Amplification of MDS1\/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer. Cancer Res 2007; 67: 3074\u20133084.","journal-title":"Cancer Res"},{"key":"BFonc2013375_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nrc1299","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R et al. A census of human cancer genes. Nat Rev Cancer 2004; 4: 177\u2013183.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2013375_CR11","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.cell.2006.06.008","volume":"125","author":"M Kim","year":"2006","unstructured":"Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 2006; 125: 1269\u20131281.","journal-title":"Cell"},{"key":"BFonc2013375_CR12","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.cell.2006.05.030","volume":"125","author":"L Zender","year":"2006","unstructured":"Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006; 125: 1253\u20131267.","journal-title":"Cell"},{"key":"BFonc2013375_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1535-6108(01)00002-2","volume":"1","author":"S Orsulic","year":"2002","unstructured":"Orsulic S, Li Y, Soslow RA, Vitale-Cross LA, Gutkind JS, Varmus HE . Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 2002; 1: 53\u201362.","journal-title":"Cancer Cell"},{"key":"BFonc2013375_CR14","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.1073\/pnas.0502256102","volume":"102","author":"D Xing","year":"2005","unstructured":"Xing D, Orsulic S . A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance. Proc Natl Acad Sci USA 2005; 102: 6936\u20136941.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013375_CR15","doi-asserted-by":"publisher","first-page":"8949","DOI":"10.1158\/0008-5472.CAN-06-1495","volume":"66","author":"D Xing","year":"2006","unstructured":"Xing D, Orsulic S . A mouse model for the molecular characterization of brca1-associated ovarian carcinoma. Cancer Res 2006; 66: 8949\u20138953.","journal-title":"Cancer Res"},{"key":"BFonc2013375_CR16","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.cell.2013.02.014","volume":"152","author":"TI Lee","year":"2013","unstructured":"Lee TI, Young RA . Transcriptional regulation and its misregulation in disease. Cell 2013; 152: 1237\u20131251.","journal-title":"Cell"},{"key":"BFonc2013375_CR17","doi-asserted-by":"publisher","first-page":"17093","DOI":"10.1073\/pnas.0707938104","volume":"104","author":"J Miao","year":"2007","unstructured":"Miao J, Wang Z, Provencher H, Muir B, Dahiya S, Carney E et al. HOXB13 promotes ovarian cancer progression. Proc Natl Acad Sci USA 2007; 104: 17093\u201317098.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013375_CR18","doi-asserted-by":"publisher","first-page":"e28077","DOI":"10.1371\/journal.pone.0028077","volume":"6","author":"CK McCann","year":"2011","unstructured":"McCann CK, Growdon WB, Kulkarni-Datar K, Curley MD, Friel AM, Proctor JL et al. Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model. PLoS One 2011; 6: e28077.","journal-title":"PLoS One"},{"key":"BFonc2013375_CR19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.ygyno.2012.11.029","volume":"128","author":"C Ivan","year":"2013","unstructured":"Ivan C, Hu W, Bottsford-Miller J, Zand B, Dalton HJ, Liu T et al. Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer. Gynecol Oncol 2013; 128: 506\u2013511.","journal-title":"Gynecol Oncol"},{"key":"BFonc2013375_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1749-6632.2003.tb07463.x","volume":"991","author":"JP Burbach","year":"2003","unstructured":"Burbach JP, Smits S, Smidt MP . Transcription factors in the development of midbrain dopamine neurons. Ann NY Acad Sci 2003; 991: 61\u201368.","journal-title":"Ann NY Acad Sci"},{"key":"BFonc2013375_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1242\/dev.02745","volume":"134","author":"C Guo","year":"2007","unstructured":"Guo C, Qiu HY, Huang Y, Chen H, Yang RQ, Chen SD et al. Lmx1b is essential for Fgf8 and Wnt1 expression in the isthmic organizer during tectum and cerebellum development in mice. Development 2007; 134: 317\u2013325.","journal-title":"Development"},{"key":"BFonc2013375_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0960-9822(00)00002-6","volume":"4","author":"T Jacks","year":"1994","unstructured":"Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994; 4: 1\u20137.","journal-title":"Curr Biol"},{"key":"BFonc2013375_CR23","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/ng747","volume":"29","author":"J Jonkers","year":"2001","unstructured":"Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A . Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 2001; 29: 418\u2013425.","journal-title":"Nat Genet"},{"key":"BFonc2013375_CR24","doi-asserted-by":"publisher","first-page":"10069","DOI":"10.1073\/pnas.0703900104","volume":"104","author":"SA Mani","year":"2007","unstructured":"Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA 2007; 104: 10069\u201310074.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013375_CR25","doi-asserted-by":"publisher","first-page":"15449","DOI":"10.1073\/pnas.1004900107","volume":"107","author":"JH Taube","year":"2010","unstructured":"Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 2010; 107: 15449\u201315454.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2013375_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng0598-47","volume":"19","author":"SD Dreyer","year":"1998","unstructured":"Dreyer SD, Zhou G, Baldini A, Winterpacht A, Zabel B, Cole W et al. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 1998; 19: 47\u201350.","journal-title":"Nat Genet"},{"key":"BFonc2013375_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ng0598-51","volume":"19","author":"H Chen","year":"1998","unstructured":"Chen H, Lun Y, Ovchinnikov D, Kokubo H, Oberg KC, Pepicelli CV et al. Limb and kidney defects in Lmx1b mutant mice suggest an involvement of LMX1B in human nail patella syndrome. Nat Genet 1998; 19: 51\u201355.","journal-title":"Nat Genet"},{"key":"BFonc2013375_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ccr.2009.10.018","volume":"16","author":"SC Mok","year":"2009","unstructured":"Mok SC, Bonome T, Vathipadiekal V, Bell A, Johnson ME, Wong KK et al. A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell 2009; 16: 521\u2013532.","journal-title":"Cancer Cell"},{"key":"BFonc2013375_CR29","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-09-3912","volume":"70","author":"L Hernandez","year":"2010","unstructured":"Hernandez L, Hsu SC, Davidson B, Birrer MJ, Kohn EC, Annunziata CM . Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer. Cancer Res 2010; 70: 4005\u20134014.","journal-title":"Cancer Res"},{"key":"BFonc2013375_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0925-4773(99)00314-7","volume":"91","author":"I Bach","year":"2000","unstructured":"Bach I . The LIM domain: regulation by association. Mech Dev 2000; 91: 5\u201317.","journal-title":"Mech Dev"},{"key":"BFonc2013375_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11033-004-7657-z","volume":"32","author":"CS Hunter","year":"2005","unstructured":"Hunter CS, Rhodes SJ . LIM-homeodomain genes in mammalian development and human disease. Mol Biol Rep 2005; 32: 67\u201377.","journal-title":"Mol Biol Rep"},{"key":"BFonc2013375_CR32","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev.bi.63.070194.002415","volume":"63","author":"WJ Gehring","year":"1994","unstructured":"Gehring WJ, Affolter M, Burglin T . Homeodomain proteins. Annu Rev Biochem. 1994; 63: 487\u2013526.","journal-title":"Annu Rev Biochem."},{"issue":"Pt 4","key":"BFonc2013375_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1529-8817.2005.00191.x","volume":"69","author":"I McIntosh","year":"2005","unstructured":"McIntosh I, Dunston JA, Liu L, Hoover-Fong JE, Sweeney E . Nail patella syndrome revisited: 50 years after linkage. Ann Hum Genet 2005; 69 (Pt 4): 349\u2013363.","journal-title":"Ann Hum Genet"},{"key":"BFonc2013375_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00467-002-0911-5","volume":"17","author":"EM Bongers","year":"2002","unstructured":"Bongers EM, Gubler MC, Knoers NV . Nail-patella syndrome. Overview on clinical and molecular findings. Pediatr Nephrol 2002; 17: 703\u2013712.","journal-title":"Pediatr Nephrol"},{"key":"BFonc2013375_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1203\/01.PDR.0000157674.63621.2C","volume":"57","author":"U Sato","year":"2005","unstructured":"Sato U, Kitanaka S, Sekine T, Takahashi S, Ashida A, Igarashi T . Functional characterization of LMX1B mutations associated with nail-patella syndrome. Pediatr Res 2005; 57: 783\u2013788.","journal-title":"Pediatr Res"},{"key":"BFonc2013375_CR36","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10552-011-9745-4","volume":"22","author":"KL White","year":"2011","unstructured":"White KL, Rider DN, Kalli KR, Knutson KL, Jarvik GP, Goode EL . Genomics of the NF-kappaB signaling pathway: hypothesized role in ovarian cancer. Cancer Causes Control 2011; 22: 785\u2013801.","journal-title":"Cancer Causes Control"},{"key":"BFonc2013375_CR37","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1128\/MCB.17.7.3488","volume":"17","author":"JD Johnson","year":"1997","unstructured":"Johnson JD, Zhang W, Rudnick A, Rutter WJ, German MS . Transcriptional synergy between LIM-homeodomain proteins and basic helix-loop-helix proteins: the LIM2 domain determines specificity. Mol Cell Biol 1997; 17: 3488\u20133496.","journal-title":"Mol Cell Biol"},{"key":"BFonc2013375_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.yexcr.2008.10.012","volume":"315","author":"A Rascle","year":"2009","unstructured":"Rascle A, Neumann T, Raschta AS, Neumann A, Heining E, Kastner J et al. The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes. Exp Cell Res 2009; 315: 76\u201396.","journal-title":"Exp Cell Res"},{"key":"BFonc2013375_CR39","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M . Immunity, inflammation, and cancer. Cell 2010; 140: 883\u2013899.","journal-title":"Cell"},{"key":"BFonc2013375_CR40","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R . STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9: 798\u2013809.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2013375_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","volume":"21","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M . Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 2010; 21: 11\u201319.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFonc2013375_CR42","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M . Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441: 431\u2013436.","journal-title":"Nature"},{"key":"BFonc2013375_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/07853890903405753","volume":"42","author":"A Mantovani","year":"2010","unstructured":"Mantovani A, Garlanda C, Allavena P . Molecular pathways and targets in cancer-related inflammation. Ann Med 2010; 42: 161\u2013170.","journal-title":"Ann Med"},{"key":"BFonc2013375_CR44","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djq127","volume":"102","author":"G Liu","year":"2010","unstructured":"Liu G, Yang G, Chang B, Mercado-Uribe I, Huang M, Zheng J et al. Stanniocalcin 1 and ovarian tumorigenesis. J Natl Cancer Inst 2010; 102: 812\u2013827.","journal-title":"J Natl Cancer Inst"},{"key":"BFonc2013375_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/(SICI)1526-968X(200001)26:1<15::AID-GENE5>3.0.CO;2-V","volume":"26","author":"CL Pressman","year":"2000","unstructured":"Pressman CL, Chen H, Johnson RL . LMX1B, a LIM homeodomain class transcription factor, is necessary for normal development of multiple tissues in the anterior segment of the murine eye. Genesis 2000; 26: 15\u201325.","journal-title":"Genesis"},{"key":"BFonc2013375_CR46","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1126\/science.1204040","volume":"331","author":"MR Stratton","year":"2011","unstructured":"Stratton MR . Exploring the genomes of cancer cells: progress and promise. Science 2011; 331: 1553\u20131558.","journal-title":"Science"},{"key":"BFonc2013375_CR47","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1158\/0008-5472.CAN-03-3380","volume":"64","author":"J Liu","year":"2004","unstructured":"Liu J, Yang G, Thompson-Lanza JA, Glassman A, Hayes K, Patterson A et al. A genetically defined model for human ovarian cancer. Cancer Res 2004; 64: 1655\u20131663.","journal-title":"Cancer Res"},{"key":"BFonc2013375_CR48","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/NEN.0b013e3181ba3952","volume":"68","author":"D Gabeau-Lacet","year":"2009","unstructured":"Gabeau-Lacet D, Engler D, Gupta S, Scangas GA, Betensky RA, Barker FG II et al. Genomic profiling of atypical meningiomas associates gain of 1q with poor clinical outcome. J Neuropathol Exp Neurol 2009; 68: 1155\u20131165.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFonc2013375_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/gcc.2870130203","volume":"13","author":"G Mohapatra","year":"1995","unstructured":"Mohapatra G, Kim DH, Feuerstein BG . Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes Chromosomes Cancer 1995; 13: 86\u201393.","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2013375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013375","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2013375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:44:59Z","timestamp":1647891899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2013375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,23]]},"references-count":49,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2014,8,14]]}},"alternative-id":["BFonc2013375"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.375","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,23]]},"assertion":[{"value":"11 September 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}